Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.
Lilly beats Novo in bellwether head-to-head weight loss study
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS